title: Primary breast cancer induces pulmonary vascular hyperpermeability and promotes metastasis via the VEGF-PKC pathway.
abstract: The lung is one of the most frequent target organs for breast cancer metastasis. When breast cancer cells from a primary tumor do not colonize the lung, which we named the premetastatic phase, the microenvironment of the lung has already been influenced by the primary tumor. However, little is known about the exact premetastatic alteration and regulatory mechanisms of the lung. Here, we used 4T1 cells (a mouse breast cancer cell line which can specifically metastasize to the lung) to build a mouse breast cancer model. We found that primary breast tumor induced increased pulmonary vascular permeability in the premetastatic phase, which facilitated the leakage of rhodamine-dextran and the extravasation of intravenous therapy injected cancer cells. Furthermore, tight junctions (TJs) were disrupted, and the expression of zonula occludens-1(ZO-1), one of the most important components of tight junctions, was decreased in the premetastatic lung. In addition, elevated serum vascular endothelial growth factor (VEGF) was involved in the destabilization of tight junctions and the VEGF antagonist bevacizumab reversed the primary tumor-induced vascular hyperpermeability. Moreover, activation of the protein kinase C (PKC) pathway disrupted the integrity of TJs and accordingly, the disruption could be alleviated by blocking VEGF. Taken together, these data demonstrate that primary breast cancer may induce tight junction disruptions in the premetastatic lung via the VEGF-PKC pathway and promote pulmonary vascular hyperpermeability before metastasis. © 2015 Wiley Periodicals, Inc.
authors.affiliation: Cancer Therapy and Research Center, Shandong Provincial Hospital, Shandong University, Jinan, PR China.
authors.forename: Man
authors.initials: M
authors.lastname: Jiang
authors.affiliation: Cancer Therapy and Research Center, Shandong Provincial Hospital, Shandong University, Jinan, PR China.
authors.forename: Chengyong
authors.initials: C
authors.lastname: Qin
authors.affiliation: Cancer Therapy and Research Center, Shandong Provincial Hospital, Shandong University, Jinan, PR China.
authors.forename: Mingyong
authors.initials: M
authors.lastname: Han
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000378:metabolism*; D045744:Cell Line, Tumor; D003911:Dextrans / Q000378:metabolism; D042783:Endothelial Cells / Q000166:cytology*; D005260:Female; D005456:Fluorescent Dyes / Q000378:metabolism; D008168:Lung / Q000098:blood supply* / Q000166:cytology / Q000473:pathology; D008175:Lung Neoplasms / Q000098:blood supply / Q000378:metabolism / Q000556:secondary*; D051379:Mice; D009362:Neoplasm Metastasis; D011493:Protein Kinase C / Q000378:metabolism*; D012235:Rhodamines / Q000378:metabolism; D015398:Signal Transduction; D019108:Tight Junctions / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
chemical_list: D003911:Dextrans; D005456:Fluorescent Dyes; C067661:Fluoro-Ruby; D012235:Rhodamines; D042461:Vascular Endothelial Growth Factor A; C467480:vascular endothelial growth factor A, mouse; D011493:Protein Kinase C
keywords: PKC; VEGF; breast cancer; premetastatic phase; tight junctions